Ninety One (UK)’s West Pharmaceutical WST Stock Holding History

Ninety One (UK)’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$32M	Sell	86,378 -6,654	-7%	-$2.35M	0.07%	141
2026 Q2	$33.4M	Sell	93,032 -26,199	-22%	-$8.01M	0.07%	133
2026 Q1	$29.9M	Buy	119,231 +17,343	+17%	+$4.32M	0.07%	121
2025 Q4	$28M	Buy	101,888 +3,970	+4%	+$1.09M	0.06%	119
2025 Q3	$25.7M	Sell	97,918 -2,707	-3%	-$658K	0.06%	126
2025 Q2	$22M	Sell	100,625 -11,885	-11%	-$2.54M	0.05%	126
2025 Q1	$25.2M	Buy	112,510 +28,235	+34%	+$7.78M	0.07%	126
2024 Q4	$27.6M	Sell	84,275 -3,623	-4%	-$1.14M	0.07%	123
2024 Q3	$26.4M	Buy	87,898 +55,372	+170%	+$17M	0.07%	121
2024 Q2	$10.7M	Sell	32,526 -1,800	-5%	-$636K	0.03%	151
2024 Q1	$13.6M	Hold	34,326	–	–	0.04%	149
2023 Q4	$12.1M	Buy	34,326 +6,143	+22%	+$2.17M	0.04%	147
2023 Q3	$10.6M	Hold	28,183	–	–	0.03%	148
2023 Q2	$10.8M	Sell	28,183 -285	-1%	-$102K	0.03%	152
2023 Q1	$9.9M	Buy	+28,468	New	+$8.32M	0.03%	156

Other funds holding WST

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

MCG

McCollum Christoferson Group Amherst, New York $343M AUM 13.42% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Tran Capital Management San Rafael, California $873M AUM 51.28% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

BZWA

Blue Zone Wealth Advisors Los Angeles, California $636M AUM 19.4% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Ninety One (UK)'s WST Position: Q3 2026 in Review

Ninety One (UK) reduced its West Pharmaceutical (WST) stake by 7.2% in Q3 2026, selling an estimated $2.35M and leaving 86,378 shares worth $32M. The position accounts for 0.07% of the portfolio, ranked #141.

Ninety One (UK) first reported a position in WST in Q1 2023 and has held it in 15 quarters since. The position peaked at $33.4M in Q2 2026. 115 funds tracked by Wall St. Rank hold WST as of Q3 2026.

Ninety One (UK) held 86,378 shares of West Pharmaceutical worth $32M as of Q3 2026.
Ninety One (UK) sold 6,654 West Pharmaceutical shares in Q3 2026, an estimated $2.35M.
West Pharmaceutical made up 0.07% of Ninety One (UK)'s portfolio in Q3 2026, its #141 holding.
Ninety One (UK) first reported a position in West Pharmaceutical in Q1 2023 and has held it in 15 quarters since.
Ninety One (UK)'s West Pharmaceutical position peaked at $33.4M in Q2 2026.
115 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Ninety One (UK)'s 13F filing for Q3 2026, filed 15 Oct 2026.